News & HighlightsNews
Study explains why checkpoint inhibitors so adept at fighting cancer may also leave patients vulnerable to infections
New insights could fine-tune this immunotherapy to avoid a common side effect without sacrificing efficacy.
Newly discovered neurons change our understanding of how the brain handles hunger
A new cell type provides a missing piece of the neural network regulating appetite.
A new chemistry for CRISPR
It acts as a sort of molecular fumigator to battle phages and plasmids.
The decision to eat may come down to these three neurons
Manipulating a newly identified neural circuit can curb appetite—or spur massive overeating.
In studying the mating rituals of fruit flies, scientists may have learned something about how brains evolve
Researchers have identified how the architecture of brain circuits helps different species flexibly adapt to new mating signals across evolutionary timeframes.
West Nile infections are spiking. Here’s why the percentage of severe cases is so small
An autoimmune condition makes certain people much more susceptible to West Nile virus and many other severe viral diseases. In the future, a screening process could reveal if you’re at risk.  
Surprising reason that B cells benefit from booster shots
New research solves the mystery of how two different types B cells work in tandem to fight off re-infections, with implications for vaccine boosting strategies.
Could a bout of COVID protect you from a severe case of flu?
New findings on how past viral respiratory infections affect future, unrelated ones could lead to therapies for boosting general antiviral immunity—and potentially better pandemic preparedness.
Svetlana Mojsov: Interactive timeline
Why a promising breast cancer drug doesn’t work—and how to improve it
A treatment that appears effective in cancers such as myelofibrosis consistently fails in breast cancer clinical trials. A new study explains why.
View
View